The University of Chicago Header Logo

Connection

Richard A. Larson to Brazil

Back to Details
This is a "connection" page, showing publications Richard A. Larson has written about Brazil.
Richard A. Larson
Connection Strength
0.025
Brazil
  1. Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial. Lancet Oncol. 2011 Sep; 12(9):841-51.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.